BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23776152)

  • 1. Hyperphagia among patients with Bardet-Biedl syndrome.
    Sherafat-Kazemzadeh R; Ivey L; Kahn SR; Sapp JC; Hicks MD; Kim RC; Krause AJ; Shomaker LB; Biesecker LG; Han JC; Yanovski JA
    Pediatr Obes; 2013 Oct; 8(5):e64-7. PubMed ID: 23776152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study.
    Forsythe E; Mallya UG; Yang M; Huber C; Cala ML; Greatsinger A; Hagopian E; Pomeroy J; Haqq AM
    Orphanet J Rare Dis; 2023 Jul; 18(1):181. PubMed ID: 37415214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey.
    Forsythe E; Mallya UG; Yang M; Huber C; Cala ML; Greatsinger A; Hagopian E; Pomeroy J; Haqq AM
    Orphanet J Rare Dis; 2023 Jul; 18(1):182. PubMed ID: 37415189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome.
    Pomeroy J; Krentz AD; Richardson JG; Berg RL; VanWormer JJ; Haws RM
    Pediatr Obes; 2021 Feb; 16(2):e12703. PubMed ID: 32700463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.
    Feuillan PP; Ng D; Han JC; Sapp JC; Wetsch K; Spaulding E; Zheng YC; Caruso RC; Brooks BP; Johnston JJ; Yanovski JA; Biesecker LG
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E528-35. PubMed ID: 21209035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results.
    Forsythe E; Haws RM; Argente J; Beales P; Martos-Moreno GÁ; Dollfus H; Chirila C; Gnanasakthy A; Buckley BC; Mallya UG; Clément K; Haqq AM
    Orphanet J Rare Dis; 2023 Jan; 18(1):12. PubMed ID: 36647077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction.
    Tomlinson JW
    Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():13-24. PubMed ID: 38302651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus in Bardet Biedl syndrome.
    Pomeroy J; Offenwanger KM; Timmler T
    Curr Opin Endocrinol Diabetes Obes; 2023 Feb; 30(1):27-31. PubMed ID: 36476576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism in Bardet-Biedl syndrome.
    Grace C; Beales P; Summerbell C; Jebb SA; Wright A; Parker D; Kopelman P
    Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1319-24. PubMed ID: 14574341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.
    Büscher AK; Cetiner M; Büscher R; Wingen AM; Hauffa BP; Hoyer PF
    Pediatr Nephrol; 2012 Nov; 27(11):2065-2071. PubMed ID: 22669322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population.
    Mujahid S; Hunt KF; Cheah YS; Forsythe E; Hazlehurst JM; Sparks K; Mohammed S; Tomlinson JW; Amiel SA; Carroll PV; Beales PL; Huda MSB; McGowan BM
    J Clin Endocrinol Metab; 2018 May; 103(5):1834-1841. PubMed ID: 29409041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status and implication of research on Bardet-Biedl syndrome].
    Shen T; Yan XM; Xiao CJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):570-3. PubMed ID: 24078572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the obesity associated with Bardet-Biedl syndrome.
    Guo DF; Rahmouni K
    Trends Endocrinol Metab; 2011 Jul; 22(7):286-93. PubMed ID: 21514177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BBSome: a nexus controlling energy metabolism in the brain.
    Blaess S; Wachten D
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome.
    Lazareva J; Brady SM; Yanovski JA
    Expert Opin Pharmacother; 2023 Apr; 24(6):667-674. PubMed ID: 37013719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bardet-Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best-practice management.
    Shoemaker A
    Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():25-33. PubMed ID: 38383825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal features of Bardet Biedl syndrome: A single center experience.
    Atmış B; Karabay-Bayazıt A; Melek E; Bişgin A; Anarat A
    Turk J Pediatr; 2019; 61(2):186-192. PubMed ID: 31951329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interview-Based Patient- and Caregiver-Reported Experiences of Hunger and Improved Quality of Life with Setmelanotide Treatment in Bardet-Biedl Syndrome.
    Ervin C; Norcross L; Mallya UG; Fehnel S; Mittleman RS; Webster M; Haqq AM; Haws RM
    Adv Ther; 2023 May; 40(5):2394-2411. PubMed ID: 36961653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Bardet-Biedl syndrome complicated with intracranial hypertension in a Japanese child.
    Saida K; Inaba Y; Hirano M; Satake W; Toda T; Suzuki Y; Sudo A; Noda S; Hidaka Y; Hirabayashi K; Imai H; Kurokawa T; Koike K
    Brain Dev; 2014 Sep; 36(8):721-4. PubMed ID: 24290075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue function and insulin sensitivity in syndromic obesity of Bardet-Biedl syndrome.
    Baig S; Wanninayake S; Foggensteiner L; Elhassan YS; Manolopoulos K; Ali S; Lassen PB; Clément K; Steeds RP; Tomlinson JW; Geberhiwot T
    Int J Obes (Lond); 2023 May; 47(5):382-390. PubMed ID: 36807608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.